Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence
Steven J Bernick1, Sunanda Kane21Department of Gastroenterology, Naval Medical Center, San Diego California; 2Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USAAbstract: Ulcerative colitis is a chronic condition that requires long-term treatment. The first-line thera...
Main Authors: | Steven J Bernick, Sunanda Kane |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-06-01
|
Series: | Patient Related Outcome Measures |
Online Access: | http://www.dovepress.com/optimizing-use-of-5-asa-in-the-treatment-of-ulcerative-colitis-focus-o-a4598 |
Similar Items
-
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
by: Mitra Debanjali, et al.
Published: (2012-09-01) -
Exacerbation of Ulcerative Colitis following Administration of 5-ASA Enemas
by: Barbara A. Young, et al.
Published: (1989-01-01) -
Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
by: Tripathi K, et al.
Published: (2021-08-01) -
Adherence in ulcerative colitis: an overview
by: Testa A, et al.
Published: (2017-02-01) -
Medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Moshkovska, Tetyana
Published: (2011)